Oprelvekin has caused allergic or hypersensitivity reactions, including anaphylaxis. Administration of oprelvekin should be permanently discontinued in any patient who develops an allergic or hypersensitivity reaction (see WARNINGS, CONTRAINDICATIONS, ADVERSE REACTIONS, Immunogenecity in package insert).